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                                          ABSTRACT OF DISSERTATION 
 
 
 
 
                            IDENTIFICATION OF CIS-ACTING ELEMENTS  
                          CONTROLLING GENE EXPRESSION IN S. neurona 
  
 Sarcocystis neurona is an apicomplexan parasite that is a major cause of 
equine protozoal myeloencephalitis (EPM).  During intracellular development of S. 
neurona, many genes are temporally regulated.  To better understand gene regulation, it 
is important to identify and characterize regulatory elements controlling gene expression 
in S. neurona.  To perform this study, it was essential to establish transfection system for 
this parasite.  Hence, the 5’ flanking region of the SnSAG1 gene was isolated from a 
genomic library and used to construct expression plasmids.  In transient assays, the 
reporter molecules β-galactosidase (β-gal) and yellow fluorescent protein (YFP) were 
expressed by electroporated S. neurona, thereby confirming the feasibility of performing 
molecular genetic experiments in this organism.  Stable transformation of S. neurona was 
achieved using a mutant dihydrofolate reductase thymidylate synthase (DHFR-TS) gene 
of T. gondii that confers resistance to pyrimethamine.  This selection system was used to 
create transgenic S. neurona that stably express β-gal and YFP.  These transgenic clones 
were shown to be useful for analyzing growth rate of parasites in-vitro and for assessing 
drug sensitivities.  To uncover possible sequence elements involved in promoter activity, 
the 5’ flanking regions of five S. neurona genes were subjected to comparative analysis.  
This revealed the presence of a 7-base conserved motif GCGTCTC. Using a dual 
luciferase assay system, the SnSAG1 promoter was subjected to functional analysis. The 
motif GAGACGC located between -136 and -129 upstream of the transcription start site 
was found to be essential for SnSAG1 expression.  This motif functions in an orientation 
dependent manner and was shown to play a role in binding nuclear proteins of S. 
neurona. 
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Chapter One: Introduction 
I. Sarcocystis neurona 
1. Taxonomy 
Sarcocystis neurona is an obligatory intracellular parasite classified under the 
phylum Apicomplexa.  The phylum includes pathogens of both medical and veterinary 
importance such as Toxoplasma gondii, Plasmodium spp., Cryptosporidium parvum, 
Babesia spp and Eimeria spp.  Sarcocystis neurona is identified as a major cause of 
equine protozoal myeloencephalitis (EPM) in horses [1].  
2. Life cycle 
 Sarcocystis neurona makes use of dual host system to complete its life cycle 
wherein opossums (Didelphis virginiana) [2] act as definitive hosts and various small 
mammals such as raccoons (Procyon lotor) [3], nine-banded armadillos (Dasypus 
novemcinctus) [4] and striped skunks (Mephitis mephitis) [5] can serve as intermediate 
hosts (Fig 1.1).  Opossums excrete sporocysts in feces after ingesting muscles containing 
S. neurona sarcocysts.  When the intermediate host ingests sporocysts, sporozoites are 
released in the intestine where they invade intestinal epithelial cells.  After multiple 
rounds of asexual propagation, merozoites enter skeletal and cardiac muscles and form 
tissue cysts, called sarcocysts.  When an opossum feeds on the muscles of an intermediate 
host containing sarcocysts, the parasite undergoes sexual propagation in the intestinal 
epithelial cells leading to the formation of oocysts.  Horses become infected after 
ingesting feed and water contaminated with sporocysts of S. neurona.  Horses are 
considered as aberrant hosts since tissue cyst formation has not been commonly seen in 
these animals [6].  However, a recent study demonstrated tissue cyst formation in an 
infected foal [7].  
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3. Equine protozoal myeloencephalitis  
 Equine protozoal myeloencephalitis (EPM) is a progressively debilitating 
neurological disease in horses [8].  Sarcocystis neurona is considered as a major 
causative agent of this disease, while Neospora hughesi has also been identified as a 
cause in a small percentage cases of EPM [9].  In horses, S. neurona infection appears to 
be confined only to the central nervous system.  Clinical signs of EPM vary depending 
upon the site of infection; e.g., involvement of the cerebrum may cause behavioral 
changes or seizures while lesions in the brainstem and spinal cord may cause gait 
abnormalities.  Extensive damage to grey matter that innervates muscles of the limbs can 
cause weakness and atrophy of the innervated muscles [10].  One of the helpful clinical 
symptoms in horses with EPM is asymmetric gate deficit accompanied by focal muscle 
atrophy [6]. 
4. Ultrastructure of apicomplexan parasites 
 Apicomplexan parasites are unicellular eukaryotes and possess a distinct set of 
structures and organelles at the apical end of the cell.  Toxoplasma gondii is one of the 
well-studied organisms in this phylum.  At the anterior end of the parasite is a special 
structure called the conoid surrounded by 2 preconoidal rings on top.  Two microtubules 
about 400 nm in length extend from the preconoidal rings and pass through the center of 
conoid [11].  At the posterior end of the conoid is the polar ring from which 22 
microtubules arise and extend two thirds of the length of the parasite body [12].  The 
plasma membrane forms the outer layer of the cell, and just beneath is the inner 
membrane complex (IMC), made of flat membranous vesicles [13].  The IMC extends 
from the anterior to the posterior pole with an interruption at the micropore.  This 
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micropore is hypothesized to play a role in nutrient uptake by endocytosis [14].  The IMC 
together with the plasma membrane is referred to as the pellicle. The surface of T. gondii 
is covered by an array of glycosyl phosphatidyl inositol (GPI)-anchored proteins 
designated as surface antigens (SAGs) [15].   
The process of invasion of a host cell by apicomplexan parasites is an active 
process i.e., the parasites make use of their actomyosin motor to gain entry into a host 
cell [16]. Toxoplasma gondii is also equipped with a special set of secretory organelles 
that are essential for the invasion, intracellular survival, and egress from the host cell.  
Cigar shaped organelles called micronemes are located at the apical end of the parasite 
near the conoid.  The initial contact with a host cell results in elevation of intracellular 
Ca2+ that leads to secretion of microneme (MIC) proteins to the parasite surface [17].  
The microneme proteins play a role in establishing firm contact between parasite and the 
host cell, which has proven to be critical for cell invasion [18] [19].  Rhoptries are club 
shaped organelles located near the apical end, and proteins from this organelle are 
released as the invasion proceeds.  Rhoptry (ROP) proteins are believed to play a role in 
formation of the parasitophorous vacuole within which the parasite resides during its 
intracellular life [20].  Toxoplasma gondii associates with host cell organelles such as 
mitochondria and endoplasmic reticulum through ROP proteins [21, 22].  Dense granules 
are uniformly present through out and proteins (GRA) from this organelle are discharged 
after the invasion process is almost complete.  Dense granule proteins (GRA) modify the 
parasitophorous vacuole and are believed to help the parasite acquire nutrients from the 
host cell [23].  A chloroplast-like organelle called the apicoplast is also present in these 
organisms, the function of which is not clearly understood [24].   
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Sarcocystis neurona shares most features of the T. gondii, although there are some 
distinct differences.  In particular, S. neurona does not have rhoptries in merozoites stage 
and is not surrounded by a parasitophorous vacuole when present inside a host cell [25] 
[6].  
5. Cell division  
After a S. neurona merozoite invades a host cell, it goes through a developmental 
process termed endopolygeny.  This process involves a total of 6 replication cycles that 
results in the formation of 64 merozoites.  However, the first 5 cycles involve only 
chromosomal duplication and segregation, thus resulting in a 32N cell.  Nuclear division 
and cytokinesis coincide with the completion of the sixth cycle, leading to the production 
of 64 merozoites [26].  The newly-formed merozoites can either remain in the same host 
cell or they escape the cell and invade nearby host cells. 
6. Molecular biology 
 Recent studies have begun to provide some insight into the molecular biology of 
S. neurona.  About 15000 expressed sequence tags (EST) are now available for S. 
neurona [27] and an additional 6300 ESTs have been produced for the closely related 
parasite S. falcatula.  Comparative analysis of ESTs in apicomplexan parasites revealed 
that 22 of the top 25 abundantly expressed genes are unique to S. neurona [28].  Of the 
remaining three, two were similar to surface antigens and the third was similar to 
ubiquitin like protein [28].  This EST database has facilitated the identification and 
characterization of S. neurona virulence factors such as surface antigens and secretory 
proteins.  Four major surface antigens have been characterized in S. neurona, and these 
have been designated as SnSAG1, SnSAG2, SnSAG3 and SnSAG4 based on the order of 
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their discovery [29].  These are GPI-anchored proteins and share homology with surface 
antigens of T. gondii.  Two secretory proteins have also been characterized in S. neurona 
and these include SnMIC10 [30] and SnNTP [92].  
II. Gene regulation by transcription initiation in eukaryotes 
1. Core promoter and distal regulatory elements 
 In a eukaryotic cell, only a subset of genes is expressed at any given time. This 
fine regulation of gene expression is achieved through several different mechanisms such 
as histone modification, DNA methylation, transcription initiation, splicing of mRNA, 
stability of mRNA, post-translational modification, protein degradation etc.  Of these, 
transcription initiation is a common and an important mode of gene regulation.  
Transcription of protein coding-genes in higher eukaryotes is carried out by RNA 
polymerase II, a multisubunit enzyme that catalyzes the synthesis of mRNA from a DNA 
template.   
The cis-acting elements that play a role in transcription are well defined in 
metazoans, and these include core promoter elements, enhancers, silencers and insulator 
sequences.  The term core promoter can be defined as the minimal segment of DNA that 
is sufficient to direct accurate transcription initiation by the RNA polymerase II 
machinery [31].  The core promoter motifs are located ~35 bp, either upstream or 
downstream of the transcription start site and include TATA box [32], initiator (Inr) [33], 
TFIIB recognition element (BRE) [34] and downstream promoter element (DPE) [35] 
[36].  However, not all genes have the full complement of core promoter elements.  A 
gene may contain all or some or none of these core promoter motifs. For example, 
analysis of the database of human genes indicated that only 32% of potential promoters 
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contained the TATA box that is located about 25-30 bases upstream of transcriptional 
start sites in metazoans [37].  In yeast, however, the TATA box is present at variable 
locations; i.e., 40-100 bases upstream of the initiator [38].  The consensus sequence for 
the TATA box is TATAAAG with one or two mismatches [39].  The initiator element is 
also a core promoter motif and is responsible for transcription initiation from a specific 
nucleotide.  It is found in both TATA box-containing as well as TATA-less promoters.   
The consensus sequence for the initiator in mammals is Py Py A (+1) N T/A Py 
Py with A being the common start nucleotide [40].  However the start nucleotide may not 
necessarily be adenosine.  It can be any nucleotide near the vicinity of the initiator.  The 
BRE is located immediately upstream of the TATA box and binds transcription factor 
TFIIB in a sequence-specific manner.  The consensus sequence for BRE is G/C-G/C-
G/A-C-G-C-C, and the 3’C is immediately followed by the 5’ T of the TATA box [34]. 
The DPE is another core promoter motif that is commonly found in TATA-less 
promoters [41].  It is located +28 to +32 nucleotides downstream of the transcription start 
site and has the consensus sequence Py Py A N T/A Py Py in mammals.  The DPE 
functions in association with the Inr to initiate transcription in TATA-less promoters [35], 
and the spacing between the Inr and DPE is very critical for transcription initiation.  
Enhancer or silencer elements can be located either near the core promoter, several kb 
either upstream or downstream from the transcription start site or within introns, and can 
either activate or repress transcription, respectively.  Insulator elements restrict enhancer 
or silencer elements associated with one gene from inappropriately regulating 
neighboring genes and also avoid the spread of heterochromatin formation, thus defining 
the boundary of a gene [42]. 
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2. Assembly of transcriptional machinery on core promoter and transcription initiation 
 One of the early steps in transcription initiation is the recognition of the TATA 
box by transcription factor TFIID.  TFIID is a multisubunit protein made of TATA 
binding protein (TBP) and 13 TBP associated factors (TAFs) [31].  TBP is a small 30 kD 
protein that binds the TATA box in the minor groove in a sequence specific manner [43].  
In TATA-less promoters, the initiator together with the DPE can initiate transcription by 
interacting with TFIID.  For example TAFII150 and TAFII250, which are components of 
TFIID, bind Inr in a sequence specific manner [41].  When TBP binds the TATA box, it 
forms a saddle around the DNA with its inner face contacting DNA, while the large outer 
surface is available for interaction with other proteins.  The binding of TBP follows 
bending of DNA by ~800 that provides a larger space for close interaction of transcription 
factors and RNA polymerase compared to a linear fragment of DNA [44].  This event is 
followed by sequential binding of general transcription factors (GTFs) – TFIIA, TFIIB, 
RNA polymerase II –TFIIF complex, TFIIE, TFIIH.  This complex is referred to as the 
preinitiation complex (PIC) [31].  The transcription factor TFIIH has many catalytic units 
associated with it that includes ATPase, helicase and kinase activity.  Using its kinase 
activity, TFIIH phosphorylates the C terminal domain (CTD) of RNA polymerase II [45].  
This process is an essential step for promoter clearance.  Most of the TFII factors are 
released from the PIC and RNA polymerase II begins the process of elongation along the 
DNA template. 
III. Cis-acting elements in Apicomplexa 
 T. gondii is one of the well studied apicomplexan parasite [46]. Sequence analysis 
of the 5’ flanking region of a major surface antigen gene, SAG1 indicated the presence of 
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six tandemly-repeated 27-base motifs about 70 bases upstream of the first transcription 
start site [47].  Nested 5’ deletion analysis showed that a minimum of two 27-bp repeats 
are essential for promoter activity above the basal level.  The SAG1 promoter when 
placed in a reverse orientation provided promoter activity similar to the wild type 
construct thus indicating that it functions in an orientation independent manner [47].  
Interestingly, a central heptamer motif A/TGAGACG present in the 27-bp repeats of the 
SAG1 promoter was also found in promoters of genes coding for dense granule proteins 
(GRA1, GRA2, GRA5 and GRA6) and tubulin (Tub) [47-51].  The motif was found in 
both orientations (WGAGACG or CGTCTCW), in different copy number, and at variable 
locations in the 5’ flanking region of these promoters.  Deletion experiments showed that 
regions containing only one motif (the most proximal to transcription start site) are 
sufficient for basal promoter activity of GRA2, and mutation of this motif abolished 
promoter activity [52].  However, some genes of T. gondii such as NTPase and DHFR-TS 
also contain this motif in the 5’ flanking region, but mapping studies indicated that this 
motif did not play a role in transcription initiation [53, 54].   
BAG1 is a stage specific small heat shock protein in bradyzoites of T. gondii [55].  
Transient transfection experiments indicated that a 324-bp 5’ flanking region is sufficient 
to confer stage-specific expression [56].  T. gondii has two genes of enolase (ENO1 and 
ENO2) that are stage specific; i.e., ENO1 is expressed in bradyzoites and ENO2 is 
expressed in the tachyzoite stage [57, 58].  The promoter regions of both enolase genes 
did not show any homology with each other, and neither contains the WGAGACG motif. 
A region –1245 to –625 acts as a repressor of ENO1 in tachyzoites [59].  The ENO2 
promoter region contains 2 repression regions (–1929 to –1067 and –456 to –222) that 
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block expression in bradyzoites.  Electrophoresis mobility shift assays demonstrated the 
presence of DNA-binding proteins in tachyzoite and bradyzoite nuclear lysates that bound 
to stress response elements (STRE), heat shock-like elements (HSE) and other cis-
regulatory elements in the upstream regulatory regions of ENO1 and ENO2 [59].  
In Plasmodium spp, the identification of cis-acting elements and the 
corresponding trans-acting factors has been a difficult task, as intergenic regions are AT 
rich and regions resembling classical TATA motifs are abundant upstream of most genes 
[60].  Deletion analysis of the glycophorin binding protein 130 (GBP130) promoter in P. 
falciparum indicated that a 37-bp region located 507 bases upstream of the transcription 
start site is essential for efficient promoter activity, and mutational analysis showed that 
the 5-bp element GTATT present in this sequence is a critical cis-acting element [61].  
CDP-diacylglycerol synthase (CDS) is an enzyme involved in phospholipid metabolism 
in P. falciparum.  Promoter analysis of CDS indicated that a 24-bp region, 1605 bases 
upstream of transcription start site is required for efficient transcriptional activity [62].  
Bioinformatic and functional analysis of a P. falciparum heat shock protein (hsp) gene 
family indicated that a palindromic G box (A/GNGGGGC/A) is involved in transcription 
[63].  A recent study demonstrated that a consensus TATA box is present 81 bases 
upstream of the transcription start site and 186 bases upstream of the transcription start 
site in the promoter regions of knob-associated histidine rich-protein (kahrp) & GBP-130 
respectively in P. falciparum [64].  The study also showed that native P. falciparum 
TATA binding protein (PfTBP) interacts with the TATA boxes in these gene promoters. 
IV. Project rationale 
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 Intracellular development of S. neurona is a complex process during which many 
genes are temporally regulated [30].  For example SnMIC10, a microneme protein is not 
expressed until terminal stages of endopolygeny [30]. It is likely that there are regulatory 
sequences upstream of these genes that control expression of proteins at different stages 
of development.  To understand gene regulation it is important to identify and 
characterize regulatory elements controlling gene expression in S. neurona.  As a first 
step towards this objective molecular genetic transfection system will be established to 
study this parasite.  Using transient transfection system regulatory elements controlling 
gene expression in S. neurona will be identified. 
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Figure 1.1.  Life-cycle of S. neurona.  Opossums act as definitive host of S. neurona and 
excrete sporocysts in feces.  Small mammals such as armadillos, raccoons and skunks 
serve as intermediate hosts. When the intermediate hosts ingest sporocysts of S. neurona, 
tissue-cysts referred to as sarcocysts are formed in the muscle.  Horses become infected 
after ingesting feed and water contaminated with sporocysts of S. neurona.  
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Chapter Two: Molecular genetic transfection of the coccidian parasite Sarcocystis 
neurona 
Introduction 
Sarcocystis neurona is an obligate intracellular parasite and the major causative 
agent of equine protozoal myeloencephalitis (EPM) [6].  S. neurona is classified in the 
phylum Apicomplexa, which includes pathogens of both medical and veterinary 
importance such as Plasmodium spp., Toxoplasma gondii, Cryptosporidium spp., 
Neospora spp.. S. neurona utilizes the opossum as its definitive host [2], and various 
small mammals can serve as intermediate hosts [4, 5, 65, 66].  Horses are considered 
aberrant hosts since tissue cyst formation has not been observed in these animals.  But a 
recent study indicates that horses can be natural intermediate hosts [7].  In infected 
horses, S. neurona can parasitize all regions of the central nervous system, and clinical 
signs depend on the site affected.  
Recent studies have begun to provide some insight into the molecular biology of 
S. neurona.  Over 15,000 expressed sequence tags (EST) are now available for S. 
neurona [27].  This sequence database has facilitated identification and characterization 
of several parasite virulence factors such as surface antigens [29] and secretory proteins 
like SnMIC10 [30] and SnNTP1 [92].  Although S. neurona exhibits many features of the 
Apicomplexa, it possesses several distinct qualities such as a lack of rhoptries in the 
merozoite stage, the absence of a parasitophorous vacuole, and cell division by 
endopolygeny [6].  During endopolygeny, the parasite undergoes 6 replication cycles that 
results in formation 64 daughter merozoites.  This prolonged developmental process has 
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made S. neurona a tractable model for cell development and division by apicomplexan 
organisms [26]. 
Molecular genetic capabilities are invaluable for investigating the biology of 
organisms, including parasites.  Genetic transfection of an apicomplexan parasite was 
first accomplished in T. gondii [67].  Subsequently, transfection has been achieved in 
Plasmodium [68] [69], Neospora caninum [70] and Eimeria tenella [71].  The 
development of reverse genetic tools in these unicellular pathogens has aided in a variety 
of studies examining various biological processes such as gene regulation [47], host cell 
invasion [72] and pathogenesis [73].  The objective of this study was to develop 
molecular genetic tools for S. neurona, thereby allowing more in-depth examination of 
the biology of this parasite.  Here we describe transient transfection and a stable 
transformation system for S. neurona.  
Materials and methods 
2.1 Parasite cultures 
S. neurona strain SN3 was propagated as merozoites by serial passage in bovine 
turbinate (BT) cells that were maintained in RPMI 1640 medium supplemented with 10% 
fetal bovine serum, 2 mM sodium pyruvate, Pen/Strep Fungizone (Bio Whittaker, Inc).  
Freshly lysed extracellular parasites were passed once through 20 G, 23 G and 25 G 
needles, and purified from the cell debris with 3.0 µm membrane filters, as described 
previously [30].  
2.2 Construction and screening of a genomic library  
S. neurona genomic DNA was isolated from a freshly-lysed culture of merozoites 
purified as described above. Merozoites were suspended in preheated lysis buffer 
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containing 100 mM EDTA (pH 8.0), 10 mM Tris HCl (pH 8.0), 1% Sodium lauryl 
sarcosyl and 2mg/ml of Proteinase-K and incubated overnight at 500C.  Genomic DNA 
was extracted three times with phenol:chloroform:isoamyl alcohol, twice with 
chloroform:isoamyl alcohol, precipitated with ethanol and resuspended in 10 mM Tris 
(pH 8.0), 1 mM EDTA, 1 mg/ml RNase A.  Cosmid library construction was 
accomplished according to protocols from the manufacturer (Stratagene).  Briefly, the 
chromosomal DNA was partially digested with Sau3AI and ligated into the BamHI site 
of Supercos-1.  The ligation reaction was packaged into phage heads using Gigapack® III 
XL packaging extract (Stratagene) and transduced into XL1-Blue MR strain of E.coli. To 
obtain a SnSAG1 genomic clone, colony lifts of the cosmid library were screened with a 
digoxigenin labeled SnSAG1 DNA probe using DIG High Prime Labeling and Detection 
kit II (Roche Molecular Biochemicals).  The 5’ flanking region of the SnSAG1 genomic 
clone was sequenced using ABI Prism™ Big Dye Terminator Cycle sequencing reaction 
mix (PE applied biosystems).  Reactions were purified with AutoSeq™ G-50 columns 
and analyzed on ABI 310 genetic analyzer (PE Applied Biosystems).  Sequences were 
manually edited and analyzed using Vector NTI Advance™ 9.0 (Informax™, 
Invitrogen). 
2.3 Plasmid constructs 
Plasmid vectors for expression of yellow fluorescent protein (YFP), β-
galactosidase (β-gal) and dihydrofolate reductase thymidylate synthase (DHFR-TS) are 
shown in Fig 1.  The TubYFP-YFP/sagCAT plasmid [74] was digested with HindIII and 
BglII to remove the 4.1 kb fragment containing the CAT expression cassette and tubulin 
promoter of T.gondii.  A 788 bp fragment of the SnSAG1 5’ flanking region was 
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amplified using a forward primer that created a HindIII site (primer, 5’-
ACTGAAGCTTAACAGTGAGGCAGATATGGC) and a reverse primer that added a 
BglII site (primer, 5’- ACTGACAGATCT GCGAGAATGACAGATGGACAG).   The 
resulting PCR product was digested with HindIII and BglII and cloned into the 
HindIII/BglII-digested TubYFP-YFP/sagCAT to make the plasmid pSnSAG1/YFP-YFP. 
The  GRA1 promoter in the previously described vector pGRA1/LacZ [70] was 
excised with HindIII and NsiI, and replaced with the 5’ flanking region of SnSAG1 
amplified using primers that contained HindIII and NsiI sites (forward primer, 5- 
ACTGAAGCT TAACAGTGAGGCAGATATGGC; reverse primer, 5’-
ACTGACCATATGCTGCGAGAAT GACAGATGGACAG) to make pSnSAG1/LacZ.      
The DHFR-TS ORF was amplified using primers that created an NsiI site at the 
start codon and a PacI site at the stop codon (forward primer-5’ 
ACTGACATGCATAAACCGGTGTGTCTGG; reverse primer-
5’ACTGACTTAATTAACTAGACAGCCATCTCCATCTG).  The amplification product 
was digested with NsiI and PacI, and cloned in place of the LacZ ORF of pSnSAG1/LacZ 
to make pSnSAG1/DHFR-TS. 
The SnSAG1 5’ flanking region, DHFR-TS ORF and TgSAG1 3’ UTR was 
amplified from pSnSAG1/DHFR-TS with primers that created NotI and BamHI sites ( 
forward primer, 5’- ACTGACGCGGCCGCAACAGTGAGGCAGATATGGC; reverse 
primer, 5’-ACTGACGGATCCTGTCGACGGCGATCAACATC) and cloned into NotI, 
BamHI-digested pSnSAG1/YFP-YFP to make pSnSAG1/YFP-YFP-pSnSAG1/DHFR-
TS.  
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To generate pSnSAG1/LacZ-pSnSAG1/DHFR-TS, the SnSAG1 promoter, Lac-Z 
ORF and TgSAG1 3’ UTR was excised from pSnSAG1/LacZ with HindIII and BamHI 
and inserted into HindIII and BamHI digested pSnSAG1/YFP-YFP-pSnSAG1/DHFR-TS 
replacing the YFP expression cassette.  All PCR reactions were performed using Klen 
Taq polymerase (Sigma) to reduce mutations introduced by the polymerase. 
2.4 Parasite transfections 
For transfection, freshly-lysed S. neurona merozoites were washed with HHE and 
resuspended in Cytomix buffer supplemented with 2mM ATP and 5mM glutathione [67].  
About 40 µg of plasmid DNA, purified by QIAfilter™ Maxi kit (Qiagen), was mixed 
with 2x107 parasites in a 2-mm gap cuvette (BTX) and electroporated at 2 kV, 129Ω 
using a BTX ECM 600 electroporation system.  Transfected parasites were allowed to 
recover for 10 min and transferred to a confluent monolayer of BT cells.  
2.5 Microscopic analysis of YFP and β-gal expressing merozoites 
Monolayers of BT cells were prepared in 4 well Lab-Tek chamber ІІ slides 
(Nalgene Nunc International) coated with poly-L-lysine or on 24 well plates (Falcon®). 
Approximately 1x105 transfected parasites were added to each chamber or well and the 
slides were incubated at 370 C in 5% CO2 for 48 hours.  Infected monolayers were 
washed thrice with PBS and fixed with 2.5% formalin, 0.25% gluteraldehyde in PBS for 
15 min at 40C.  For YFP expressing parasites, the slides were rinsed with PBS and 
mounted in Vectashield mounting medium with DAPI (Vector laboratories Inc.) and 
examined with a Zeiss axioscope equipped for phase contrast and epiflourescence 
microscopy.  To visualize β-gal expressing parasites, the cells were permeabilized with 
0.2% TX-100/PBS for 30 min and blocked with 10% NGS/PBS for 30 min.  Slides were 
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then incubated with 1:500 diluted MAb against E.coli β-gal (Developmental Studies 
Hybridoma Bank) for 1 hour at room temperature.  Slides were rinsed and incubated with 
FITC-conjugated anti-mouse antibody (1:200).  The slides were then mounted and 
examined as mentioned previously. 
 2.6 Selection of pyrimethamine resistant clones 
About 1x107 transfected parasites were added to each well in a 6 well plate 
containing BT cell monolayers.  After 24 hours, the medium was changed to RPMI/3% 
FBS containing 10 µM pyrimethamine.  The cultures were maintained till the monolayer 
was 90% lysed.   Parasites were passed through needles and inoculated into a T25 flask 
for a second round of selection with 10 µM pyrimethamine.  After disruption of the 
monolayer, parasites were cloned by limiting dilution as described previously [75].  
Briefly, freshly lysed parasites were passed through needles, filtered, counted and diluted 
to 4x102/ml in RPMI/10% FBS.  A 10 µl aliquot of the suspension (4 merozoites) was 
added to each well of a 96 well plate.  Wells containing a single plaque were identified 
after 7-10 days, after which the medium was changed every 5 days.  Once the parasites 
lysed the monolayer, the content of the well was transferred to a single well of a 24 well 
plate for expansion of the parasite culture.  After lysis of the monolayer in the 24-well 
plate, the merozoites were transferred to a T25 flask. 
2.7 Southern blot analysis 
Genomic DNA was isolated from transgenic clones as described in section 2.2. 
Approximately 5 µg of DNA was digested with restriction enzymes, electrophoresed on 
agarose gel, and transferred by Southern blot [76] to a nylon membrane (Hybond™-N, 
Amersham biosciences).  The membrane was hybridized with digoxigenin-labeled DNA 
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probe generated from either a portion of the ColE1 origin of replication and ampicillin 
resistance gene) of the pBluescript SK+ or from the SnSAG1 5’ flanking region. 
2.8 Fluorescence Activated Cell Sorting (FACS) and flow cytometry 
Freshly lysed parasites were passed through needles, filtered and resuspended in 
PBS. The parasites were sorted at room temperature under aseptic conditions using a 
FACSCalibur® instrument (Becton Dickinson, San Jose, CA).  Approximately 1x104 
fluorescent parasites were collected using the single cell sort mode.  Merozoites were 
pelleted by centrifugation and cloned by limiting dilution.  The intensity of fluorescent 
clones was analyzed by further FACS analysis. 
2.9 β-gal assays 
Pyrimethamine resistant S. neurona clones obtained after transfection with 
pSnSAG1/LacZ-pSnSAG1/DHFR-TS were pelleted by centrifugation and resuspended in 
lysis buffer (100 mM HEPES, pH 8.0, 1 mM MgSO4, 1% Triton X-100, 5 Mm 
dithiothreitol).  Enzyme activity was analyzed according to procedure described 
previously [77] using 2 mM chlorophenol red-β-galactopyranoside (CPRG) (Boehringer-
Mannheim) as substrate.  Reactions were performed in 96 well plates for 30 min at 370C 
and then read at A570 in a microplate reader (Molecular Devices Corporation). T. gondii 
(RH-2F) and N. caninum (Nc-LacZ) [75] stably expressing β-gal were used as positive 
controls in the assays.  Growth assays of the SN3(LacZ) clone were performed as 
described previously [78].  Briefly, freshly lysed parasites purified from cell debris were 
added onto 96 well plate (3x105 per well) containing confluent monolayer of BT cells and 
varying concentrations of drugs.  Culture plates were incubated at 370C in 5% CO2.  At 
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different time points (days) post infection, infected host cells were lysed and enzyme 
activity was determined. 
2.9 Growth assays using YFP 
Growth assays of YFP expressing parasites were performed according to 
procedures described previously [74].  Briefly, BT cells were seeded onto black, 384 well 
tissue culture treated plates with optical bottoms (Falcon/Becton-Dickinson).  Freshly 
lysed SN3(YFP).A1 parasites purified from cell debris were resuspended in culture 
medium without phenol red, and serially diluted in the presence of the drug.  Plates were 
then incubated at 370 C, 5% CO2, and read daily in a BMG fluostar fluorescent reader 
(Hoffenberg, Germany).  
Results 
3.1 Isolation of 5’ flanking region of SnSAG1 
In order to obtain the presumptive promoter region for the SnSAG1 gene, a S. 
neurona genomic library was screened with a DNA probe for the SnSAG1 ORF [29].  
PCR, Southern blot and sequencing analyses confirmed the presence of the SnSAG1 locus 
in a single hybridizing cosmid clone.  About 800 bases of sequence upstream of the ATG 
start codon was obtained, which presumably contains the promoter elements necessary 
for gene transcription.  Sequence information for the SnSAG1 5’ flank has been deposited 
in GenBank (DQ286460). 
3.2 Transient expression of β-gal and YFP in S. neurona 
To demonstrate the feasibility of transgenic expression in S. neurona, 788 bp of 
the SnSAG1 5’ flanking region (676 bp non-coding region and 112 bp 5’ UTR) was 
amplified by PCR and directionally cloned upstream of the reporter genes LacZ and YFP 
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(Fig 2.1).  Although β-gal was not detected in S. neurona populations transfected with the 
pSnSAG1/LacZ plasmid, examination by immunoflourecence microscopy at 72 hours 
post-transfection revealed expression of β-gal in a small proportion of the parasites (Fig 
2.2A).  Similarly, electroporation of merozoites with the pSnSAG1/YFP-YFP plasmid 
yielded a comparable sub-population of parasites that exhibited YFP expression, as 
revealed by fluorescence microscopy (Fig 2.2B).  Uniform fluorescence of the merozoites 
or the developing schizonts was observed for both reporter molecules, thus suggesting 
cytoplasmic localization of the proteins.  These results demonstrated the feasibility of 
transient expression of foreign genes in S. neurona merozoites using the SnSAG1 gene 5’ 
flanking region to control transgene expression. Enumerations of fluorescent organisms 
from two separate electroporations revealed approximately 11% and 7% of the parasite 
population expressing the transgene (data not shown), although other electroporations 
appeared to yield a lower proportion of transfected parasites.  Therefore, the absence of 
detectable β-gal activity in the populations of parasites transfected with pSnSAG1/LacZ 
was attributed to the poor efficiency of transfection.   
3.3 Stable transfection of S. neurona 
To establish stable transgenic clones of S. neurona, a T. gondii DHFR-TS allele 
that confers resistance to pyrimethamine [79] was cloned into S. neurona transfection 
plasmid under transcriptional control of the SnSAG1 promoter (Fig 2.1).  The resulting 
pSnSAG1/DHFR-TS plasmid was electroporated into extracellular merozoites and 
transfected parasites were inoculated onto BT cell monolayers.  Development of parasites 
in the presence of 10 µM pyrimethamine was apparent after 1 week, and the monolayer 
was 90% lysed after 4 weeks of drug selection.  Parasite growth was not observed in 
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mock transfected parasites.  To confirm that plasmid DNA had integrated into 
chromosomes, genomic DNA from eight pyrimethamine resistant (PyrR) clones was 
analyzed by Southern blot using a probe specific for the pBluescript vector.  The 
hybridized fragments migrated slower than the linearized plasmid (Fig 2.3A), indicating 
that the plasmid was integrated into the parasite genome.  Five clones appeared to be 
siblings, while three clones were unique.  Two hybridizing fragments were observed in 
clone F2 indicating two integration events.  
Genomic DNA from PyrR recombinant clones was also digested with NdeI, which 
does not cleave pSnSAG1/DHFR-TS.  Hybridization with the SnSAG1 gene 5’ flanking 
region revealed a restriction fragment from the endogenous SnSAG1 locus in both wild-
type SN3 and the PyrR clones (Fig 2.3B).  A second, slower migrating fragment from the 
pSnSAG1/DHFR-TS transgene was also observed in PyrR clones.  The transgene in each 
PyrR clone did not co-migrate with the pSnSAG1/DHFR-TS plasmid and exhibited 
hybridization intensity that was equal to the endogenous SAG1 fragment.  These data are 
consistent with single-copy integration of the plasmid into the genome of the recombinant 
clones.  Additionally, the plasmid had not integrated by homologous recombination at the 
SnSAG1 locus since migration of the endogenous fragment was not altered in the PyrR 
clones. 
3.4 Transgenic S. neurona expressing β-gal 
A stable cell line of SN3 expressing β-gal was obtained by transfection of 
extracellular merozoites with plasmid pSnSAG1/LacZ-pSnSAG1/DHFR-TS that 
contained both the DHFR-TS and Lac-Z expression cassettes (Fig 2.1).  Analysis of β-gal 
expression in the SN3(LacZ) clone indicated that enzymatic activity could be detected 
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with as few as 2x103 transgenic parasites (Fig 2.4).  β-gal activity in the S. neurona clone 
was approximately 50% lower than the Nc(LacZ) N.  caninum clone and the RH-2F T. 
gondii clone.  
 3.5 Transgenic S. neurona expressing YFP 
To establish transgenic parasites that stably express YFP, the plasmids 
pSnSAG1/YFP-YFP (200 µg) and pSnSAG1/DHFR-TS (20 µg) were cotransfected into 
extracellular merozoites, and stable transformants were selected in the presence of 10 µM 
pyrimethamine.  After 4 weeks of drug selection, a very small proportion (<0.5%) of the 
drug resistant parasites were fluorescent.  FACS was employed to enrich for YFP-
expressing parasites (Fig 2.5A), and the population of fluorescent merozoites was 
expanded and subsequently cloned by limiting dilution.  Southern blot analysis of five 
YFP-expressing clones using a DNA probe specific for the pBluescript vector indicated 
that the clones were all siblings and contained a single copy of each transfected plasmid 
(Fig 2.5B).  Fluorescent cytometry of one clone, SN3(YFP).A1 indicated 1000-fold 
greater fluorescence in the recombinant parasites relative to wild-type SN3 (Fig 2.5C).  
3.6 Use of transgenic parasites in growth assays 
Recombinant parasites expressing reporter molecules have proven useful for a 
variety of experimental purposes.  To demonstrate the utility of using the transgenic S. 
neurona clones for assessing in-vitro growth of parasites, the S. neurona clones 
SN3(YFP1).A1 and SN3(LacZ) were grown in the presence of diclazuril, toltrazuril or 
pyrimethamine.  A progressive increase in relative fluorescence (Fig 2.6) or β-gal activity 
(Fig 2.7) was observed over 8-10 days when parasites were grown in the absence of drug 
treatment.  With increasing concentrations of drugs, the relative fluorescence or β-gal 
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activity increased at a slower rate than non-treated cultures, consistent with reduced 
growth of the parasites.  In the presence of pyrimethamine, parasites grew at 
concentrations higher than the lethal dose of 2.5 µM [80], as expected since they express 
a mutant DHFR-TS allele that confers resistance to this folate inhibitor.  However, a high 
level of pyrimethamine (40 µM) was capable of inhibiting parasite growth.  Importantly, 
the data generated with the SN3(YFP).A1 clone corresponded well with the data obtained 
with the SN3(LacZ) clone, thereby confirming that either reporter molecule can be used 
to reliably monitor parasite growth. 
Discussion 
Development of DNA transfection capabilities provides a powerful approach for 
genetic dissection of an organism.  In an effort to enhance investigation of the 
apicomplexan S. neurona, we have established methods for expressing foreign genes in 
this parasite.  Reporter molecules YFP and β-gal were efficiently expressed in S. neurona 
transfected with plasmid constructs containing SnSAG1 promoter region to drive 
transgene transcription.  As SnSAG1 is highly represented in the S. neurona EST database 
[27] and appears to be constitutively expressed during intracellular development [29], it 
was expected to provide an excellent promoter for both transient expression and stable 
transformation of this parasite.  Indeed, we successfully generated recombinant S. 
neurona that are pyrimethamine resistant and stably express YFP and β-gal.  
A number of positive selection markers have been developed for the related 
apicomplexan T. gondii.  These include chloramphenicol acetyltransferase (cat) [81], 
mutant dihydrofolate reductase [79], hypoxanthine xanthine guanine phosphoribosyl 
transferase (HXGPRT) [82], phleomycin (ble) [83] and tryptophan (trp) synthase [84].  
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Of these, mutant dihydrofolate reductase gene seems to be a highly efficient selectable 
marker, but its use has been discouraged in T. gondii since it renders parasites resistant to 
a primary chemotherapeutic agent for the treatment of toxoplasmosis [85].  Given that S. 
neurona is not a human pathogen, the mutant DHFR-TS can be used as a selectable 
marker without posing a hazard to investigators working with pyrimethamine resistant 
parasites. 
Parasites that stably express the reporter molecules β-gal or YFP have been shown 
previously to be useful in monitoring in-vitro growth and primary screening of new 
chemotherapeutic agents [78, 86].  As both assays are performed in microtiter plates, 
multiple drugs can be screened simultaneously for anti-coccidial activity.  Reporter 
molecules like green fluorescent protein (GFP) have also proven useful as fusion proteins 
to identify signal motifs that direct proteins to specific organelles [87].  Similarly use of a 
promoterless GFP allowed for identification of novel proteins targeted to various 
subcellular compartments [88].  
The development of molecular genetic capabilities for S. neurona has opened 
many new avenues of investigation into the biology of this parasite.  The genetic tools 
described here in have already proven valuable for examining development and 
segregation of the apicoplast during endopolygeny [26].  A variety of useful genetic 
manipulations are now feasible, such as gene knockouts, complementation by 
introduction of heterologous genes, and use of reporter molecules to monitor gene 
expression.  Prior studies utilizing transient transfection have implicated putative 
regulatory elements that control gene expression in T. gondii and plasmodium falciparum 
[47, 52-54, 63].  In similar fashion, cis-acting elements required for gene transcription in 
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S. neurona can be identified using transient transfection system (Chapter Three).  These 
studies should provide a better understanding of the mechanisms that temporally control 
gene expression during intracellular development. 
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Figure 2.1.  Schematic representation of plasmids used for expression of YFP, β-gal, and 
mutant DHFR-TS in S. neurona.  The 5’ flanking region of the SnSAG1 gene was 
utilized to drive transcription of the transgenes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 26
 
 
 
Figure 2.2.  S. neurona electroporated with reporter constructs transiently expressed β-gal 
(A) and YFP (B).  Parasites were transfected with either pSnSAG1/LacZ or 
pSnSAG1/YFP-YFP and inoculated onto monolayer of BT cells.  YFP expressing 
parasites were viewed with a Zeiss axioscope equipped for epiflourescence microscopy. 
β-gal expressing parasites were revealed by immunoflourecence microscopy using a 
monoclonal antibody against E.coli β-gal. Bars = 5µm. 
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Fig. 2.3. Southern blot analysis of pyrimethamine resistant (PyrR) clones of S. neurona. 
(A) Genomic DNA digested with HindIII, which cleaves at one site in the 
pSnSAG1/DHFR-TS plasmid construct (see Fig 1), was hybridized with a probe specific 
for the pBluescript vector. Clones D8, E2, G10, C8, and F2 appeared to be siblings, clone 
D10 has 2 copies of the transfected plasmid, and F6 & D4 are unique clones. (B) 
Genomic DNA was digested with NdeI, which does not cleave pSnSAG1/DHFR-TS, and 
hybridized with the SnSAG1 gene 5′ flanking region. The endogenous SnSAG1 fragment 
(arrow) was observed in wild type SN3 and the recombinant clones. The transgene 
fragments (*) did not comigrate with the pSnSAG1/DHFR-TS plasmid (supercoiled and 
nicked forms; arrowheads) and were only present in the recombinant clones. 
MW = molecular weight marker. 
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Figure 2.4. Analysis of β-gal expression in a transgenic clone of S. neurona.  Greater 
enzymatic activity was detected with increasing parasite numbers.  The T. gondii RH-2F 
and N. caninum NC (LacZ) clones that stably express β-gal were used as positive 
controls.  β-gal activity was not detected in wild-type SN3 merozoites. 
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Figure 2.5.  Isolation of S. neurona clones expressing YFP.  (A) Merozoites expressing 
YFP were selected by gating highly fluorescent cells (R1), which represented about 
0.45% of the drug resistant population.  (B) Southern blot analysis of YFP-expressing 
clones of S. neurona obtained by cotransfection of plasmids pSnSAG1/YFP-YFP and 
pSnSAG1/DHFR-TS demonstrated that all clones appeared to be siblings and have a 
single copy of each plasmid.  Genomic DNA was digested with HindIII, which cuts once 
in each plasmid, and a probe specific for pBluescript was used for hybridization. No 
HindIII sites are present in the probe sequence.  (C) SN3 wild-type and stable YFP-
expressing clone SN3 (YFP1).A1 were analyzed by flow cytometry.  Transgenic S. 
neurona were about 1000 times more fluorescent than the wild-type parasites. 
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Figure 2.6.  Growth curves of SN3 (YFP).A1 merozoites in the presence of diclazuril, 
toltrazuril and pyrimethamine.  Parasites were loaded into 384-well plates containing 
confluent monolayers of BT cells, the plates were incubated for 10 days in the presence 
of each drug at various concentrations, and relative fluorescence was read daily with a 
fluorescence plate reader.  Average values from three identical wells were used in 
plotting the growth curve. 
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Figure 2.7.  Growth curves of SN3 (LacZ) in the presence of diclazuril, toltrazuril and 
pyrimethamine.  Parasites were added (3x105 per well) into 96-well plates containing 
confluent monolayers of BT cells and varying concentrations of drugs.  At different time 
points (days) post infection, infected host cells were lysed in the wells and assayed for β-
gal activity.  Average values from three identical wells were used in plotting the growth 
curve. 
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Chapter Three: GAGACGC is a cis-acting element critical for SnSAG1 expression in 
Sarcocystis neurona 
Introduction 
 
Sarcocystis neurona is an apicomplexan parasite identified as the major cause of 
equine protozoal myeloencephalitis (EPM) in horses [6].  Opossums act as the definitive 
host for S. neurona [2], and various small mammals such as raccoons, armadillos and 
skunks [3] [4] [5] can serve as intermediate hosts.  The parasite shares many features of 
apicomplexan organisms such as an obligatory intracellular life & gliding motility and S. 
neurona EST project [27] has revealed numerous genes that are homologous to 
Toxoplasma gondii surface [29] and secretory [30] [92] antigens.  However, there are 
some distinct differences such as absence of rhoptries, parasitophorous vacuole in 
merozoite/schizont stages in S. neurona [6]. 
Apicomplexan parasites utilize a variety of mechanisms for cell division.  For 
example T. gondii divides by endodyogeny while S. neurona divides by endopolygeny.  
During S. neurona endopolygeny, it is apparent that there is temporal control of gene 
expression.  Specifically, both SnMIC10 [30] and SnNTP1 [92] are not expressed until 
terminal stages of endopolygeny.  However, the mechanism of gene regulation during 
intracellular development of S. neurona is unknown.  It is likely that there are regulatory 
elements upstream of these genes that control gene expression at different stages of 
development. 
In higher eukaryotes core promoter motifs and distal regulatory elements are well 
defined [42].  The core promoter motifs are located ~35 bases either upstream or 
downstream of the transcription start site and include TATA box [32], initiator [33], 
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TFFIIB recognition element (BRE) [34], and downstream promoter element (DPE) [35].  
However, not all genes have the full complement of core promoter elements.  A very few 
cis-acting sequence elements have been identified in apicomplexan parasites.  The 
heptanucleotide motif WGAGACG has been identified in the promoters of SAG1and 
GRA genes of Toxoplasma [47, 52] and a palindromic G-box was found in heat shock 
protein (hsp) gene family of Plasmodium spp [63].  A consensus TATA box has been 
identified in knob-associated histidine rich-protein (kahrp) & glycophorin binding 
protein 130 (GBP-130) gene promoters of P. falciparum [64].   
To gain a better understanding of gene regulation during intracellular 
development of S. neurona, we have initiated studies to define regulatory sequences in 
this organism.  As a first step towards this objective, the 5’ flanking region of SnSAG1 
was subjected to comparative and functional analysis using a recently developed 
transfection system for S. neurona (Chapter Two).  Herein, we describe the identification 
of a conserved 7-base motif that is essential for gene expression. 
Materials and Methods 
 
2.1 Parasite cultures 
 S. neurona strain SN3 was propagated as merozoites by serial passage in bovine 
turbinate (BT) cells.  BT cells were maintained in RPMI 1640 medium supplemented 
with 10% fetal bovine serum, 2 mM sodium pyruvate, and Pen/Strep Fungizone (Bio 
Whittaker, Inc).  Freshly-lysed extracellular parasites were passed once through 20 G, 23 
G and 25 G needles, and purified from the cell debris with 3.0 µm membrane filters, as 
described previously [29]. 
2.2 Isolation and analysis of S. neurona genomic DNA clones 
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To obtain genomic DNA clones of the SnSAG2, SnSAG3, SnNTP and Sarco_21 
loci, colony lifts of a S. neurona genomic cosmid library (Chapter Two) were hybridized 
with digoxigenin (DIG)-labeled DNA probes, and hybridized colonies were detected 
using DIG High Prime Labeling and Detection kit II (Roche Molecular Biochemicals).  
The 5’ flanking region of the each genomic clone was sequenced using ABI Prism™ Big 
Dye Terminator Cycle sequencing reaction mix (PE applied biosystems).  Sequencing 
reactions were purified with AutoSeq™ G-50 columns and analyzed on an ABI 310 
genetic analyzer (PE Applied Biosystems).  Sequences were manually edited and 
analyzed using Vector NTI Advance™ 9.0 (Informax™, Invitrogen). 
2.3 Total RNA isolation and 5’ RACE 
 To identify transcription start sites of SnSAG1, 5’ RACE was performed using 
First Choice® RLM-RACE (Ambion) according to the manufacturer’s instructions.  
Briefly, total RNA was purified from S. neurona merozoites using TRIZOL (Invitrogen).  
RNA was treated with calf intestinal alkaline phosphatase (CIP), and the reaction was 
stopped by phenol:chloroform extraction.  The RNA was treated with Tobacco Acid 
Pyro-phosphatase (TAP), followed by ligation of a 45-base RNA adapter using T4 RNA 
ligase.  A random-primed reverse-transcription was then performed using M-MLV 
reverse transcriptase, followed by a nested PCR.  The outer 5’ RLM-RACE PCR was 
performed using the 5’ RACE outer primer and a SnSAG1 outer primer (Table 3.1).  The 
inner 5’ RLM-RACE PCR was performed using primers 5’ RACE inner primer and a 
SnSAG1 inner primer (Table 3.1).  The amplification products were analyzed by agarose 
gel electrophoresis and nucleotide sequencing, as described above. 
2.4 Plasmid Constructions 
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 Sequences of primers used in this study are provided in Tables 3.1-3.3.  The 
renilla luciferase (RLUC) ORF was amplified from pRL-CMV (Promega) using the 
primers RLU.HindIII.F and RLU.BamHI.R that created HindIII and BamHI sites, 
respectively (Table 3.1).  The amplification product was cloned into HindIII and BamHI-
digested pBluescript SK+ to make pRLUC.  The SnSAG2 3’ flanking sequence was 
amplified from a SnSAG2 cosmid clone using primers (SnSAG2 3’.BamHI.F and SnSAG2 
3’.NotI.R) that created BamHI and NotI sites (Table 3.1), and the product was cloned into 
BamHI and NotI-digested pRLUC to make pRLUC/SnSAG2.  The SnSAG1 5’ flanking 
region was amplified using primers (SnSAG1 5’.XhoI.F and SnSAG1 5’.HindIII.R) that 
created XhoI and HindIII sites (Table 3.1), and the amplification product was ligated into 
XhoI and HindIII-digested pRLUC/SnSAG2 to make pSnSAG1/RLUC/SnSAG2.  
The firefly luciferase (FLUC) ORF of pGL2-Basic (Promega) was amplified with 
primers (FLU.HindIII.F and FLU.BamHI.R) that created HindIII and BamHI sites (Table 
3.1).  The amplification product was ligated into HindIII and BamHI-digested 
pBluescript SK+ to make pFLUC.  The SnSAG1 3’ flanking region was amplified from a 
SnSAG1 genomic clone with primers (SnSAG1 3’.BamHI.F and SnSAG1 3’.NotI.R) that 
created BamHI and NotI sites (Table 3.1).  The product was cloned into BamHI and 
NotI-digested pFLUC to make pFLUC/SnSAG1.  
Amplification of the SnSAG1 promoter fragments was performed with forward 
primers that added a XhoI site and a single reverse primer that added a HindIII site 
(SnSAG1 5’.HindIII.R; Table 3.2).  The amplification fragments were cloned upstream of 
the FLUC ORF in pFLUC/SnSAG1 to create SnSAG1 promoters that varied in length.  
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These deletion constructs were named based on the length of the promoter from the first 
transcription start site. 
Modified promoter fragments were created by overlap extension PCR [89] using 
forward (F2), reverse (R2), forward mutation (FM) and reverse mutation (RM) primers 
(Table 3.3). PCR 1 was performed using primers FM and R2, whereas PCR 2 was done 
using primers RM and F2.  The products of PCR 1 & PCR 2 were mixed and used as 
template in PCR 3, which was performed using primers F2 and R2 that contained XhoI 
and HindIII sites, respectively.  The product of PCR 3 was digested with XhoI and 
HindIII and cloned into XhoI and HindIII-digested pFLUC/SnSAG1, thus creating 
plasmids pSnSAG1(-179M1)/FLUC/SnSAG1, pSnSAG1(-136M2)/FLUC/SnSAG1, 
pSnSAG1(-136M3)/FLUC/SnSAG1 and pSnSAG1(-179M1.FLIP)/FLUC/SnSAG1.  
To replace the region between Motif 1 and 2, a PstI site was introduced one base 
upstream of Motif 2 in pSnSAG1(-136)/FLUC/SnSAG1 to make pSnSAG1(-
136.PstI)/FLUC/SnSAG1.  The amplification product obtained with primers 
Supercos.XhoI.F & Supercos.PstI.R and pSupercos 1 (Stratagene) as template was 
digested with XhoI & PstI and subcloned into XhoI & PstI-digested pSnSAG1(-
136.PstI)/FLUC/SnSAG1 to make pSnSAG1(-136R)/FLUC/SnSAG1 construct. The 
SnSAG1 promoter fragment was amplified with primers (-223.HindIII.F & -223.XhoI.R) 
that created HindIII & XhoI sites (Table 3.1) and cloned into HindIII & XhoI-digested 
pFLUC/SnSAG1 to make the pSnSAG1(-223FLIP)/FLUC/SnSAG1 construct.   
Amplification of the TgSAG1 promoter was performed with primers 
(TgSAG1.XhoI.F and TgSAG1.HindIII.R) that created XhoI & HindIII sites (Table 3.1).  
The amplification product was cloned into XhoI & HindIII-digested pFLUC/SnSAG1 & 
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pRLUC/SnSAG2 to make pTgSAG1/FLUC/SnSAG1 & pTgSAG1/RLUC/SnSAG2 
respectively.  
 All PCR reactions were performed using Klen Taq polymerase (Sigma) to reduce 
mutations introduced by the polymerase. All plasmid constructs were confirmed by 
sequencing. 
2.5 Parasite Transfections 
 Freshly-lysed S. neurona merozoites were washed with Hanks buffer, HEPES, 
EGTA (HHE) and resuspended in Cytomix buffer supplemented with 2mM ATP and 
5mM glutathione [67].  A 40 µg aliquot of the experimental FLUC luciferase plasmid and 
10 µg of the RLUC control plasmid (pSnSAG1/RLUC/SnSAG2) were mixed with 1x107 
parasites in a 2-mm gap cuvette (BTX), and the parasites were electroporated at 2 kV, 
129Ω using a BTX ECM 600 electroporation system.  Transfected parasites were allowed 
to recover for 10 min at RT and transferred to a confluent monolayer of BT cells in 6-
well plates.  
2.6 Luciferase assays 
 Seventy-two hours post-transfection, parasite cultures were analyzed for 
luciferase activity using a Dual-luciferase® reporter assay system (Promega).  Briefly, 
medium was removed from the culture plates, the monolayers were washed once with 
PBS, and 200 µl of passive lysis buffer was added to the wells.  Lysed cells were 
collected by scraping, transferred to microcentrifuge tubes, and subjected to two freeze-
thaw cycles.  20 µl of cell lysate was analyzed for firefly luciferase activity in a TD-20/20 
luminometer (Turner Designs).  Stop & Glow® reagent was added to quench FLUC 
luminescence and initiate RLUC activity, which was then quantified in the luminometer.  
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Firefly luciferase activity was normalized to the level of RLUC activity to control for 
variable transfection efficiencies.  The firefly luciferase activity observed in parasites 
transfected with pSnSAG1(-701)/FLUC/SnSAG1 was set at 100%.  
2.7 Nuclear extract preparation 
 Nuclear extracts were prepared from 2x108 S. neurona merozoites using NE-
PER® (Pierce) according to the manufacturer’s instructions.  Briefly, freshly-lysed 
merozoites were harvested and resuspended in 200 µl of ice-cold cytoplasmic extraction 
reagent (CER)-I.  The parasite lysate was incubated on ice for 10 min followed by 
addition of 11 µl of ice-cold CER-II.  The tube was incubated on ice for one minute, 
vortexed, and centrifuged at 16000 x g for 5 min.  The supernatant fraction (cytoplasmic 
extract) was discarded and the insoluble pellet containing merozoite nuclei was 
resuspended in 100 µl of ice-cold nuclei extraction reagent (NER).  The resuspension 
mixture was incubated on ice for 40 min, with vortexing every 10 min.  The tube was 
centrifuged at 16000 g for 10 min, and the supernatant (nuclear extract) fraction was 
transferred to clean tube and stored in 20 µl aliquots at -800 C. 
2.8 Electrophoresis mobility shift assay (EMSA) 
 For the EMSAs, three different probes were made. Probe 1 was a double stranded 
oligo containing wild-type copy of motif 1 (AGGAAACGAGACGCGCCAGCA). Probe 
2 was a double stranded oligo containing mutant copy of motif 1 
(AGGAAACTCACTTAGCCAGCA).  Probe 3 was a PCR product containing all 3 
motifs of SnSAG1 promoter obtained using primers (forward, 5’ 
AATGCTAGCTGTCCGGGTGC; reverse, 5’ ACAGATGGACAGCGTGTCTG).  The 
probes were end labeled with [ -32P]ATP (ICN, Costa Mesa, CA) as described previously 
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[90].  Binding reactions were performed for 30 minutes at room temperature in 10 µl 
volumes containing approximately 2 µg S. neurona nuclear extract and 1 µl ( 50,000 
cpm) radiolabeled oligonucleotide in binding buffer [4% glycerol, 1 mM MgCl2, 0.5 mM 
EDTA (pH 8.0), 0.5 mM DTT, 50 mM NaCl, 10 mM Tris (pH 7.5) and 50 µg poly(dI-
dC)].  Reaction products were separated in 4% nondenaturing polyacrylamide gels and 
analyzed with a Storm Phosphorimager System (Molecular Dynamics, Sunnyvale, CA). 
Results 
3.1 Bioinformatic analysis of 5’ flanking regions of S. neurona genes and identification of 
transcription start sites of SnSAG1 
 The sequencing of the 5’ flanking region of SnSAG1 has been described 
previously (Chapter Two). To obtain sequence for the promoter region of various S. 
neurona genes, a S. neurona genomic library was screened with probes specific for the 
SnSAG2, SnSAG3, SnNTP and Sarco_21 ORFs.  A single genomic clone for each locus 
was isolated, and approximately 0.6 kb of sequence upstream of the ATG start codon was 
obtained.  Comparative analysis of the 5’ flanking sequences using MEME and Vector 
NTI® software revealed a 7-base motif GCGTCTC that was present in either orientation 
and in variable copy numbers (Fig 1).  Additionally, the location of these motifs was 
highly variable across the different promoters.  The analysis did not reveal the standard 
eukaryotic promoter elements TATA-box, DPE, CAAT-box or TFIIB recognition 
element (BRE).  
 To determine the transcription start site of the SnSAG1 gene, 5’ RACE was 
performed.  This analysis indicated the presence of two transcription start sites (Fig 3.1).  
The first transcription start site is 88 bases upstream of ATG start codon, while the 
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second transcription start site is 122 bases upstream of the start codon.  The transcription 
start sites for the four other S. neurona genes are based on EST data and presumptive.  
3.2 Functional analysis of the SnSAG1 promoter 
 To define a S. neurona promoter, the SnSAG1 5’ flanking region was subjected to 
functional analysis using a dual luciferase reporter system.  As an initial test to establish 
the importance of both the SnSAG1 5’ and the 3’ flanking regions for gene transcription, 
parasites were transfected with plasmid constructs that lacked the 5’ flanking region, the 
3’flanking region or both.  High levels of FLUC activity were observed when the full-
length parental construct pSnSAG1(-701)/FLUC/SnSAG1 was electroporated. In 
contrast, FLUC reporter activity was not detected with the constructs pFLUC and 
pFLUC/SnSAG1, while the pSnSAG1/FLUC yielded about 40% luciferase activity 
relative to the full length construct (Fig 3.2).  These data indicated that both the 5’ and 
the 3’ flanking regions of SnSAG1 are needed for efficient expression of FLUC reporter 
gene.  
 To identify cis-acting elements that play a role in SnSAG1 gene expression (see 
Fig 3.3A), a series of SnSAG1 5’ deletion constructs were transfected into parasites and 
analyzed for FLUC reporter activity.  The FLUC activity detected from parasites 
transfected with the full length parent construct pSnSAG1(-701)/FLUC/SnSAG1 was set 
at 100%.  Transfection with the deletion constructs from -627 to -179 gave levels of 
reporter activity that was comparable to the full length (-701) promoter (Fig 3.3B).  In 
contrast, FLUC activity was not detected from parasites transfected with the -101 and -23 
constructs.  These data indicated that the 78 bp region between -179 and -101 contains 
sequences that are critical for FLUC expression. 
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 To more precisely define the sequences necessary for gene expression, the 78-bp 
region between -179 and -101 was subjected to further deletion analysis (Fig 3.4).  
Luciferase activity was detected in parasites transfected with the construct that contained 
149 bases upstream of the transcription start site (-149), while transfection with the 
plasmid construct that included 123 bases upstream of the transcription start site (-123) 
did not yield reporter activity.  These results indicated that the 26-bp region between -149 
and -123 contains sequences required for FLUC expression.  Importantly, one of three 
GCGTCTC motifs is present in this 26-base region of SnSAG1 promoter (Fig 3.3A). 
 To determine if the motif 1 (GAGACGC) located between -149 and -123 is an 
important sequence element for gene expression, constructs were made that delete or alter 
the motif, and reporter activity produced in parasites transfected with these plasmids was 
analyzed (Fig 3.5).  Parasites transfected with the -129 construct showed no reporter 
activity, while parasites transfected with plasmid that included 7-base motif GAGACGC 
(-136) yielded full promoter activity (Fig 3.5).  This indicated that motif 1 is a sequence 
element that is critical for reporter molecule expression.  To further confirm that motif 1 
is critical for expression, a construct that contained a mutant copy of motif 1 (-179M1) 
was made and promoter activity analyzed.  Luciferase activity was not detected when the 
-179M1 construct was transfected into parasites (Fig 3.5), thus confirming that the motif 1 
present between -129 and -136 is a critical sequence element that is required for FLUC 
expression.  
Two additional motifs, motif 2 and motif 3 are present in the SnSAG1 5’ flanking 
region (Fig 3.3A).  To know if these two additional motifs play a role in gene 
transcription, plasmids containing mutant copies of the motifs were constructed.  As 
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shown in Fig. 3.5, mutation of motif 2 (-136M2) reduced luciferase activity by 50% 
compared to the full-length promoter.  In contrast, mutation of motif 3 (-136M3) did not 
affect luciferase activity.  These data imply that motif 2 is involved in promoter activity 
but is not essential, while motif 3 may not be important for gene expression.  
To know if there are additional regulatory elements between motif 1 and motif 2, 
the SnSAG1 promoter region between these motifs was replaced with a heterologous 
DNA fragment of identical length.  When the resulting construct (-136R) was transfected 
into parasites, no FLUC activity was detected implying that there are sequence elements 
between motif 1 and motif 2 that are critical for gene expression. 
The GCGTCTC motif is present in forward and reverse orientations in S. neurona 
gene promoters. To know if motif 1 can function in both orientations, a construct was 
designed in which motif 1 was placed in the reverse orientation GCGTCTC (-223M1.FLIP).  
FLUC activity was not detected in parasites transfected with this construct indicating that 
orientation of motif 1 is critical for its function (Fig 3.6).  In the related apicomplexan 
parasite SAG1 promoter is able to function in reverse orientation [47]. To know if 
SnSAG1 promoter is also a divergent promoter the fragment from -223 to +85 was placed 
in reverse orientation.  Transfection of the resulting construct (-223FLIP) into parasites 
yielded about 25% FLUC activity relative to full-length construct (Fig 6).  These results 
suggest that the SnSAG1 promoter can function in reverse orientation, but at a reduced 
capacity. 
3.3 The T. gondii TgSAG1 and S. neurona SnSAG1 promoters are not efficient for 
heterologous expression 
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Motif 1, which appears to be critical for SnSAG1 expression, is very similar to the cis-
acting element WGAGACG that has been identified in some T. gondii gene promoters 
[47, 52].  To determine whether the T. gondii TgSAG1 promoter would be recognized by 
the S. neurona transcriptional machinery, S. neurona merozoites were transfected with 
pTgSAG1/FLUC/SnSAG1.  This construct yielded only 2% FLUC activity relative to the 
SnSAG1 full length promoter construct (Fig 3.7A).  Similarly, T. gondii tachyzoites 
transfected with pSnSAG1/FLUC/SnSAG1 construct produced only 4% FLUC activity 
compared to the pTgSAG1/FLUC/SnSAG1 construct (Fig 3.7B).  These data suggest that 
the promoters in T. gondii and S. neurona will not function efficiently in the heterologous 
organism, despite the similarity of the sequence motifs that have been identified as 
important for gene expression in these related species. 
3.4 Motif 1 binds S. neurona proteins 
 The functional analysis of SnSAG1 promoter indicated that motif 1 is critical; 
motif 2 is essential but not necessary and motif 3 does not play a role in gene 
transcription.  To know if motif 1 is a protein binding motif, EMSAs were performed 
with a S. neurona nuclear extract and DNA probes containing the motif.  An 
electrophoretic shift of a 21-bp probe that included the wild-type motif 1 and 14 adjacent 
nucleotides was observed after incubation with the nuclear extract (Fig 3.8).  A 100-fold 
excess of the non-labeled probe prevented protein binding to the labeled probe (Fig 3.8).  
A probe containing a mutant copy of motif 1 did not efficiently bind proteins in the 
nuclear extract nuclear extract, as revealed by a significant reduction in the amount of 
shifted probe (Fig 3.8).  A 254 bp fragment of the SnSAG1 promoter that included all 3 
motifs was similarly capable of binding proteins in the nuclear extract as shown by a 
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large complex of shifted probe (Fig 3.8).  A 100-fold excess of non-labeled probe 
abolished binding of proteins to the labeled fragment.  However, when a 100-fold excess 
of the 21-bp probe was used as competitor, the shifted complex was unaffected, 
suggesting that there are additional protein-binding sequence elements in the 254-base 
fragment.   
Discussion 
 S. neurona undergoes a complex method of cell division termed endopolygeny, 
during which there is temporal control of gene expression.  The biology of this parasite 
with regard to gene regulation has not been defined, primarily because of unavailability 
of molecular genetic tools.  The recent development of a transfection system for S. 
neurona has enabled the studies described herein aimed at identifying sequence elements 
that regulate gene expression.  In this study, we have identified a 7-base motif required 
for SnSAG1 expression.  This element appears to function in an orientation dependent 
manner by interacting with transcription factors.   
As the deletion or alteration of the motif in the SnSAG1 promoter completely 
abolishes promoter activity the GAGACGC motif may be one of the core promoter 
elements in S. neurona.  In Toxoplasma, an identical motif WGAGACG was found in the 
promoter regions of GRA1, GRA2, GRA5, GRA6 and TUB1 genes [52].  This element is 
present in either orientations, at variable locations and multiple copy number similar to 7-
base motif of S. neurona [52].  A single copy of the motif proximal to transcription start 
site is sufficient for basal promoter activity of GRA2.  Similar to our findings in this 
study, not all of theses motifs play a role in transcription of GRA genes [52].  The 
Toxoplasma SAG1 promoter contains six, tandemly-repeated, 27-base motifs and a 
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minimum of two 27-bp repeats are sufficient for promoter activity.  Interestingly, the 
heptanucleotide motif (WGAGACG) is the central core of the 27-base motifs of TgSAG1 
promoter [47].  We also identified GAGACGC motif in promoter regions of NcMIC10 
and NcNTP1 genes of N. caninum (Gaji and Howe, unpublished data).  However, this 
motif has not been described in Plasmodium spp, thus suggesting that GAGACGC motif 
is a conserved cis-acting element only in tissue dwelling coccidia. 
 In Plasmodium, the available information suggests that gene regulatory elements 
may be different from other parasites in the phylum.  A palindromic G-box 
(A/GNGGGGC/A) is involved in transcription of the hsp gene family in Plasmodium 
[63].  While no classical eukaryotic promoter elements are present hsp family gene 
promoters [63], a consensus TATA-box is present in kahrp & GBP-130 gene promoters 
that interacts with the native P. falciparum TATA binding protein [64].   
 It is unlikely that the 7-base core promoter motif is involved in developmental 
regulation of gene expression in S. neurona since the motif is present in SnSAG1, a 
constitutively expressed gene [29] and also in SnNTP1 [92], a temporally regulated gene 
during endopolygeny.  Sequence elements that act as repressors govern stage specific 
expression of enolase genes in Toxoplasma [59].  T. gondii has two genes of enolase 
(ENO1 and ENO2) that are stage specific; ENO1 is expressed in bradyzoites and ENO2 is 
expressed in tachyzoites [57, 58].  The region –1245 to –625 acts as a repressor of ENO1 
in tachyzoites and 2 repression regions in the ENO2 promoter region, (–1929 to –1067 
and –456 to –222), block expression in bradyzoites [59].  Recent studies have also 
suggested that epigenetics or chromatin remodeling is an important mode of gene 
regulation in apicomplexan parasites [91]. 
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 In summary, this is the first report describing identification of a discrete core 
promoter element in Sarcocystis species.  Further analysis of SnSAG1 promoter will help 
in identifying additional regulatory motifs and thus provide an insight about the 
mechanism of transcriptional regulation in S. neurona.   
The knowledge of cis-acting elements and transcription factors in apicomplexan 
parasites is still rudimentary.  Bioinformatic analysis using programs designed for higher 
eukaryotes may not be an efficient way of identifying regulatory sequence elements in 
apicomplexans due to sequence divergence [46].  But comparative genomics within 
Apicomplexa combined with functional analysis could be a better approach.   
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Table 3.1. Primers used in 5’ RACE & designing plasmid constructs 
 
Name Sequence 
SnSAG1 outer primer TGCATAGACCTGCATCTGAC 
SnSAG1 inner primer TAACAGTCGTTTCGCCATTGGC 
RLU.HindIII.F GATCAAGCTTAGCCACCATGGCTTCGAAAG 
RLU.BamHI.R GATCGGATCCCCGCTCTAGAATTATTGTTC 
SnSAG2 3’.BamHI.F ACTGGGATCCGGTGTGAAGATGAAATTGTC 
SnSAG2 3’.NotI.R ACTGGCGGCCGCTATGACCGTCCCGCTGTGTAA 
SnSAG1 5’.XhoI.F ACTGCTCGAGGAAACAGTGAGGCAGATATG 
SnSAG1 5’.HindIII.R ACTGACAAGCTTGCGAGAATGACAGATGGACAG 
FLU.HindIII.F GATCAAGCTTGTAAAATGGAAGACGCCAAAAAC 
FLU.BamHI.R GATCGGATCCCGTCATCGCTGAATACAGTTAC 
SnSAG1 3’.BamHI.F ACTGGGATCCTAATCCTGCCGTGTAGCGTC 
SnSAG1 3’.NotI.R ACTGGCGGCCGCCACATGGCCCAGTGCTCAC 
Supercos.XhoI.F ACTGCTCGAGGAGACGCGAGGCTGGATGG 
Supercos.PstI.R ACTGCTGCAGGGACAGCATGGCCTGCAAC 
TgSAG1.XhoI.F ACTGCTCGAGCTTTACCATGCGTCTAG 
TgSAG1.HindIII.R ACTGAAGCTTCTCGTCAAAAAACCAGAAG 
-223.HindIII.F ACTGAAGCTTCGAATCTAGATATGATGACAG 
-223.XhoI.R ACTGCTCGAGGCGAGAATGACAGATGGACAG 
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Table 3.2. Primers used in making SnSAG1 5’ deletion constructs 
 
Name of forward primer                               Sequence 
-701 ACTGCTCGAGGAAACAGTGAGGCAGATATG 
-627 ACTGCTCGAGGCTAACGCCGTAGTCTAATTG 
-478 ACTGCTCGAGCGTTGTTATCTCCACCAGGG 
-328 ACTGCTCGAGATACTGTCAGTAAACTGGTGC 
-179 ACTGCTCGAGAATGCTAGCTGTCCGGGTGC 
-101 ACTGCTCGAGCGTCATTCGTATAGGCGTAC 
-23 ACTGCTCGAGCGACCTTTAATACTTCGTTCAC 
-149 ACTGCTCGAGAAATGCAGGAAACGAGACGC 
-123 ACTGCTCGAGAAGCCGGCGTTCCGTCATAC 
-136 ACTGCTCGAGGAGACGCGCCAGCAAGCCG 
-129 ACTGCTCGAGGCCAGCAAGCCGGCGTTCC 
-223 ACTGCTCGAGCGAATCTAGATATGATGACAG 
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Table 3.3. Primers used in making SnSAG1 5’ mutant constructs by overlap extension 
PCR 
 
Primer Sequence 
Motif 1. F2 
Motif 1. R2 
Motif 1. RM 
Motif 1. FM 
ACTGCTCGAGAATGCTAGCTGTCCGGGTGC 
ACTGACAAGCTTGCGAGAATGACAGATGGACAG 
GAAATGCAGGAAACTTTTTTTGCCAGCAAGCCG 
CGGCTTGCTGGCAAAAAAAGTTTCCTGCATTTC 
Motif 2. F2 
Motif 2. R2 
Motif 2. RM 
Motif 2. FM 
ACTGCTCGAGGAGACGCGCCAGCAAGCCG 
ACTGACAAGCTTGCGAGAATGACAGATGGACAG 
GCACACATGCTTTTTTTAAATGTGCGTATC 
GATACGCACATTTAAAAAAAGCATGTGTGC 
Motif 3. F2 
Motif 3. R2 
Motif 3. RM 
Motif 3. FM 
ACTGCTCGAGGAGACGCGCCAGCAAGCCG 
ACTGACAAGCTTGCGAGAATGACAGATGGACAG 
CGTCTCAAATGTAAAAAAAGACCTTTAATA 
GATACGCACATTTAAAAAAAGCATGTGTGC 
Motif 1. FLIP. F2 
Motif 1. FLIP. R2 
Motif 1. FLIP. RM 
Motif 1. FLIP. FM 
ACTGCTCGAGAATGCTAGCTGTCCGGGTGC 
ACTGACAAGCTTGCGAGAATGACAGATGGACAG 
GAAATGCAGGAAACGCGTCTCGCCAGCAAGCCG 
CGGCTTGCTGGCGAGACGCGTTTCCTGCATTTC 
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Figure 3.1.  Schematic representation of 5’ flanking regions of S. neurona genes.  Sequence 
analysis revealed GCGTCTC motifs in either orientation, at variable locations and differing 
copy number. Direct orientation of the motif (GCGTCTC) is shown by hatched box and 
indirect orientation (GAGACGC) is represented by open box. Transcription start sites are 
shown by bent arrows.  The transcription start sites of SnSAG1 were identified by 5’ 
RACE.  The transcription start sites for the four other S. neurona genes are putative based 
on the first nucleotide in S. neurona EST database. 
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Figure 3.2.  Examination of reporter activity provided by SnSAG1 5’ and 3’ flanking 
regions.  The analysis indicated that both 5’ and 3’ flanking regions are needed for efficient 
transcription of the reporter gene.  Mean ± SEM were determined from three independent 
experiments. 
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Figure 3.3A. Schematic representation of SnSAG1 full length promoter region used in 
functional analysis. This included 701 bases of 5’ flanking region and 85 bases of 5’ UTR. 
There is one indirect copy, motif 1 (M1) and two direct copies, motif 2 (M2)& motif 3 
(M3) of GCGTCTC motifs in the 5’ flanking region. The two transcription start sites are 
shown by bent arrows. The transcription start site 88 bases upstream of ATG start codon 
was designated as first transcription start site (+1). The numbers below the motifs indicate 
distance from first transcription start site. 
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Figure 3.3B.  SnSAG1 promoter mapping by 5’ deletion analysis.  Transient luciferase 
activity of deletion mutants indicated that the cis-acting element/s required for FLUC 
expression is/are located between 179 and 101 bases upstream of the transcription start 
site.  Mean ± SEM were obtained from three independent experiments. 
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Figure 3.4.  SnSAG1 promoter mapping by 5’ deletion analysis.  Based on results of the 
previous experiment (Fig 3B), the region between -101 and -179 was subjected to further 
deletion analysis.  The results indicated that 26 bp region between -149 and -123 contains 
sequence element essential for FLUC expression.  Mean ± SEM were obtained from three 
independent experiments. 
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Figure 3.5.  Fine mapping of SnSAG1 promoter by 5’ deletion and mutational analysis. The 
results indicate that GAGACGC motif located between -129 and -136 is essential for 
FLUC expression.  Dot filled boxes in constructs in -179M1, -136M2 and -136M3 represent 
mutation of motifs 1, 2 and 3 respectively.  Zigzag line in construct -136R represents 
replacement of SnSAG1 promoter sequence between motif 1 and motif 2 by heterologous 
sequence of same length.  Mean ± SEM were obtained from three independent 
experiments. 
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Figure 3.6.  SnSAG1 promoter mapping by mutational analysis.  Orientation is important 
for functioning of motif 1 and the SnSAG1 promoter can function at a reduced capacity in 
reverse orientation.  Motif 1 is placed in reverse orientation in construct -179M1.FLIP.  In 
construct -223FLIP the SnSAG1 promoter fragment (-223 to +85) is placed in reverse 
orientation.  Open and closed block arrows in constructs -223 & -223FLIP indicate the 
orientation of SnSAG1 promoter fragment.  Mean ± SEM were determined from three 
independent experiments. 
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Figure 3.7A.  T. gondii SAG1 promoter is not well recognized by S. neurona transcription 
machinery.  S. neurona merozoites were transfected independently with 
pSnSAG1/FLU/SnSAG1 and pTgSAG1/FLUC/SnSAG1.  pSnSAG1/RLUC/SnSAG2 
was used as internal control for transfection efficiency.  The reporter activity was 
determined 72 hours post-transfection and luciferase activity obtained with SnSAG1 
promoter was set at 100%.  Mean ± SEM were determined from three independent 
experiments. 
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Figure 3.7B.  SnSAG1 promoter is not well recognized by T. gondii transcription 
machinery.  T. gondii (RH-1) tachyzoites were transfected independently with 
pSnSAG1/FLU/SnSAG1 & pTgSAG1/FLUC/SnSAG1.  pTgSAG1/RLUC/SnSAG2 was 
used as internal control for transfection efficiency.  The reporter activity was determined 
24 hours post-transfection and luciferase activity obtained with TgSAG1 promoter was 
set at 100%.  Mean ± SEM were determined from three independent experiments. 
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Figure 3.8.  Electrophoresis mobility shift assay indicated that M1 is important for 
binding to proteins in S. neurona nuclear extract.  The assay was performed using three 
labeled probes - probe 1 (Lanes 1,2,3) was 21 bp in length with wild-type copy of M1 
(straight line); probe 2 (Lanes 4,5,6) was same as probe 1, but contained mutant copy of 
M1; probe 3 (Lanes 7,8,9,10) was 254 bp in length that included all three motifs (dotted 
line).  In lane 3, non-labeled probe 1 was the competitor; in lane 6, non-labeled probe 2 
was used as the competitor; in lane 9, non-labeled probe 3 was used as the competitor and 
in lane 10, non-labeled probe 1 was used as the competitor.  Arrows indicate the location 
of the shifted probe. 
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Chapter Four: Conclusions 
S. neurona is an obligatory intracellular parasite classified in phylum Apicomplexa and is 
a major cause of EPM in horses.  The biology of this parasite with regard to host cell invasion, 
pathogenesis, metabolism, gene regulation etc has not been defined partly due to unavailability 
of molecular genetic tools.  The parasite divides by a complex process termed endopolygeny 
after invading a host cell.  During this process many genes are developmentally regulated.  It is 
important to identify regulatory sequences controlling gene expression to understand gene 
regulation.  Hence the primary objective of this study was to identify regulatory elements that 
play a role in gene expression in S. neurona.  However, to conduct this study, it was essential to 
establish transfection system for this parasite.  One of the basic components needed was 
promoters of S. neurona genes to drive expression of transgenes.  To obtain promoters of S. 
neurona genes, a cosmid based S. neurona genomic library was made and some of the highly 
expressed gene clones were isolated.  The 5’ flanking region of these gene clones were 
sequenced to obtain presumptive promoter elements that were cloned upstream of reporter genes.  
Transfection of reporter plasmid constructs into S. neurona resulted in successful expression of 
transgenes YFP & β-gal.  An important molecular genetic tool is the establishment of stable 
transformation system for an organism.  Mutant DHFR-TS allele of T. gondii has proven to be a 
strong selectable marker in related apicomplexans, T. gondii and Plasmodium spp.  The 
expression of this gene confers resistance against the drug pyrimethamine, a folate inhibitor.  
Stable transformation of S. neurona was achieved using mutant DHFR-TS.  Using this selection 
system transgenic S. neurona stably expressing reporter molecules YFP & β-gal were generated 
and were shown to be useful for assessing drug sensitivity in-vitro.  Theses transgenic parasites 
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can be used for primary screening and identification of potential drug candidates against S. 
neurona.    
After successfully establishing transfection system for S. neurona, SnSAG1 gene 
promoter was subjected to comparative and functional analysis.  Comparative analysis of 5’ 
flanking regions of S. neurona genes, SnSAG1, SnSAG2, SnSAG3, SnNTP1 and Sarco_21 
revealed a 7-base conserved motif GCGTCTC.  Dual luciferase system was used for functional 
analysis of SnSAG1 promoter.  Nested 5’ deletion and mutational analysis indicated that 
GAGACGC motif located between -136 and -129 is an essential cis-acting element for SnSAG1 
expression.  This is a protein binding motif that functions in an orientation dependent manner.  
The GAGACG motif of SnSAG1 is identical to WGAGACG element that has been shown to 
play a role in transcription of many T. gondii genes.  This motif is also present in N. caninum 
gene promoters suggesting that GAGACGC is a conserved core promoter element in tissue 
dwelling coccidia.   
The results of this study indicate that there are additional regulatory elements between 
motif 1 and 2 that are essential for transcription. Mutational analysis of the region between these 
two motifs will allow for identification of these regulatory sequences.  The 5’ UTR of SnSAG1 
can also be subjected to mutational analysis to see if there are core promoter elements similar to 
down-stream promoter element (DPE) in higher eukaryotes. The DNA foot-print analysis is also 
another important tool to identify additional protein binding motifs in the SnSAG1 promoter 
region.  The protein that interacts with motif 1 can be identified by mass spectrometry.  The 
proteins that interact with GAGACGC binding protein can be characterized using yeast two-
hybrid system. 
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The molecular pathogenesis of S. neurona is a very poorly understood process.  The route 
by which the S. neurona released in the intestine of the horse reach the central nervous system is 
not known.  Using stable transformation system transgenic parasites stably expressing reporter 
molecule firefly luciferase can be created and the path by which S. neurona travels in the body of 
the horse can be worked out.  It is also feasible to perform genetic manipulations such as gene 
knock-outs to precisely define the function of different proteins and hence virulent proteins 
involved in molecular pathogenesis of S. neurona can be identified.  The prolonged intracellular 
development and the availability of molecular genetic tools & cellular markers make S. neurona 
a useful model to study developmental biology of apicomplexan parasites.  Identification of cis-
acting elements and transcription factors that interact with these sequences will help in 
understanding the mechanism of transcriptional and developmental regulation in S. neurona.  
Those transcription factors that play a role in expression of virulent genes in S. neurona can be 
ideal drug targets for treating EPM.  
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